European project LEAP-BIO aims at bridging the gap between different European regions in licensing and partnering associated with early-stage assets, driving the growth of the small and medium biopharma companies and contributing to a more competitive European biopharma industry at a global level. It has developed an early-stage focused IP licensing digital platform for biopharma SMEs and startup companies that combines AI-powered digital tool and face-to-face partnering events on BioFIT.